SHARE
COPY LINK

COVID-19

EU approves use of Pfizer-BioNTech vaccine in children 12 and over in Europe

The European Commission authorised the use of the Pfizer-BioNTech vaccine in 12- to 15-year-olds on Friday, following the European Medicines Agency's approval of administering the jabs to adolescents earlier in the day.

EU approves use of Pfizer-BioNTech vaccine in children 12 and over in Europe
A nurse prepares a syringe with saline solution before it is diluted with the Pfizer/BioNTech vaccine at the Evonik vaccination in Hanau, western Germany (Photo by THOMAS LOHNES / AFP)

This vaccine is already approved for people aged 16 and over in the EU.

Earlier this month, US regulators authorised the vaccine for children in the 12-to-15 age group, and it is now widely available.

The European Medicines Agency said that two doses of the vaccine would be needed in adolescents and should be given at least three weeks apart, which is the same guidance as for adult use.

Individual EU states would be able to decide whether or not they wanted to offer the vaccine to the 12 to 15-year-olds.

READ ALSO: Vaccines to be made available to children 12 and over in Germany starting June

Germany said on Thursday that it would start giving the vaccine to children from 12 to 15 from June 7th, which is when vaccine prioritisation for all adults is set to end in Germany.

READ ALSO: Covid jabs for children in Germany will be an ‘individual decision’, says Health Minister

Italy has also said it would extend its vaccination campaign to the over-12s, with approval from Italy’s regulator expected by Monday.

READ ALSO: Italy to open Covid jab appointments to all over-16s from June 3rd

And Austrian capital Vienna was waiting for the EMA approval before opening up Covid-19 vaccination registrations to parents of 12- to 15-year-olds.

In Switzerland, meanwhile, children may be able to get vaccinated at the age of 10, even without their parents’ approval.

The EMA approval may help reassure parents when children go back to face-to-face teaching, but the issue is not without controversy.

A few figures in the medical community have said there is not yet enough evidence to support vaccines and their potential side effects in younger people, while others believe older and vulnerable people in less wealthy countries should be prioritised over children.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.
For members

COVID-19

What you need to know about the new Covid-19 wave in Switzerland

When the pandemic was winding down two years ago, health authorities warned that while the worst was over, Covid will keep re-emerging, in one form or another, in the future.

What you need to know about the new Covid-19 wave in Switzerland

In Switzerland, the number of laboratory-confirmed coronavirus cases has increased by around 50 percent over the last four weeks, according to the Federal Office of Public Health (FOPH).  

Add to it the undeclared cases, and that figure is even higher.

“The number of positive tests is climbing, and further increases cannot be ruled out,” FOPH said.

Overall, however, the number of infections remains low.

Why is Covid still around in Switzerland?

As epidemiologists predicted, coronavirus will keep mutating, with different strains emerging over time.

Covid’s new variants, KP.2 and KP.3, are currently circulating throughout the country, causing the number of cases to go up.

That’s because the latest variants spread fast and are particularly resistant to antibodies — which means that whatever immunity you may have built up through previous infections or vaccinations are not sufficient to stop new infections.

What are the symptoms?

The most common ones are similar to those of seasonal flu — that is, cough, fever, headache, muscle pain, cold, sore throat, as well as tiredness.

But just as with the previous bouts, some people will experience milder symptoms, while others more severe ones.

For the time being, these variants have not caused serious developments in most people, and only a small number have required hospitalisation.

What should you do if symptoms appear?

If you do become infected, FOPH recommends avoiding contact with other people, especially those who are particularly at risk of complications.

Measures imposed by the government during earlier outbreaks, such as isolation and quarantine, are not necessary at this point — though health authorities say that, similarly to to previous bouts, you should wear a mask and keep your distance.

And if you are in a high-risk group, contact your doctor immediately.

Should you get (re)vaccinated?

Ask your doctor about that.

Compulsory basic insurance will pay for the vaccine for high-risk people, and possibly their carertakers, based on doctor’s recommendations.

Others must pay for the shot out of their pockets. A dose costs around 100 francs.

Should you cancel your vacation if you test positive?

It is up to you and your own sense of responsibility.

“It would be best to cancel the flight immediately,” said Christiane Meier, vice-president of the Association of Cantonal Doctors. If you decide to go anyway, “wear a mask and keep your distance,” she added.
 
Should we expect a further increase in the number of cases after the holidays?

According to FOPH, it is not yet possible to know for sure, though this possibility can’t be excluded.

Swiss health authorities are constantly monitoring the evolution, but are not making any predictions for the moment.

What they do say is that though new variants spread fast and resist immunity, “there is no reason to panic at this stage.”

SHOW COMMENTS